Condition

Tobacco Use Disorder

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 59 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials59

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

59 shown

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansNCT07576595 · 2025-04-17

Smoking Cessation CM for Veterans With or at Risk for CancerNCT06432985 · 2025-01-29

Engaging Pharmacists to Advance Tobacco Treatment Service DeliveryNCT07501624 · 2026-02-11

ENROLLING_BY_INVITATION

Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized PatientsNCT07164404 · 2025-11-17

ACTIVE_NOT_RECRUITING

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2NCT06006143 · 2025-06-16

ACTIVE_NOT_RECRUITING

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsNCT06624137 · 2024-12-12

Smoking Cessation Program for Adults With Type 2 Diabetes Mellitus (DiMe-SALUD2 Project)NCT05885659 · 2023-09-01

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health SettingsNCT05030272 · 2021-09-21

Learn to Quit-HIV Pilot StudyNCT04609514 · 2021-01-25

Smoking Cessation Treatment for Smokers With ObesityNCT04332029 · 2020-10-07

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)NCT03873337 · 2019-04-22

Combining rTMS With Varenicline to Prevent Smoking Lapse in SchizophreniaNCT03497299 · 2018-07-01

Cardiovascular Risk Screening and Risk Reduction in Women VetsNCT02991534 · 2016-11-15

RCT of an Internet Cessation Program Plus Online Social Network for HIV+ SmokersNCT02781090 · 2016-07-06

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung NodulesNCT02169271 · 2014-11-21

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current SmokersNCT02123849 · 2014-06-01

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive CancersNCT02188563 · 2014-05-01

Lorcaserin for Preventing Weight Gain Among SmokersNCT02393547 · 2013-09-01

Memantine Hydrochloride in Helping Cancer Survivors Stop SmokingNCT01535040 · 2012-08-01

Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung CancerNCT01673711 · 2012-07-01

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsNCT01434342 · 2011-10-01

Positively Smoke Free on the Web (PSFW) for Smokers Living With HIVNCT01570595 · 2011-09-01

Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 YearsNCT01344005 · 2011-06-01

Electronic Decision Support Systems for Smokers With Severe Mental IllnessNCT01412866 · 2011-05-01

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerNCT01457469 · 2011-01-01

Zileuton With or Without Celecoxib As Chemopreventive Agents in SmokersNCT01021215 · 2010-05-01

Screening Protocol for Research ParticipantsNCT01010620 · 2009-12-01

Lung HIV Microbiome Project (Michigan Site)NCT02392182 · 2009-10-01

Acceptability of Less Harmful Alternatives to CigarettesNCT00957424 · 2009-06-01

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and ControlsNCT01214005 · 2009-06-01

p16 Methylation for Smoking CessationNCT01038492 · 2009-04-01

Phenethyl Isothiocyanate in Preventing Lung Cancer in SmokersNCT00691132 · 2009-02-01

Screening Methods in Finding Lung Cancer Early in Current or Former SmokersNCT00751660 · 2008-09-01

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingNCT00790569 · 2008-09-01

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung CancerNCT00690924 · 2008-07-17

Smoking Termination Opportunity for inPatientsNCT01141855 · 2008-05-01

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy VolunteersNCT00899262 · 2008-04-01

Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical TrailNCT00618280 · 2008-01-01

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal SputumNCT00573885 · 2008-01-01

Health Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingNCT00666978 · 2007-12-01

Varenicline Effects In Schizophrenic SmokersNCT00548470 · 2007-06-01

Green Tea Extract in Treating Current or Former Smokers With Bronchial DysplasiaNCT00611650 · 2006-10-01

Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung CancerNCT00363428 · 2006-08-01

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaNCT00368927 · 2006-08-01

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingNCT00365508 · 2006-02-01

Bupropion in Helping Adults Stop SmokingNCT00534001 · 2006-01-01

Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2NCT00158145 · 2005-09-01

Nicotine and Sensorimotor Replacement for Smoking in Smokers With SchizophreniaNCT01213524 · 2005-09-01

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1NCT00218179 · 2005-09-01

Effect of Bupropion on Smoking Behavior in Smokers With SchizophreniaNCT00218231 · 2004-01-01

Zinc Supplements in Lowering Cadmium Levels in SmokersNCT00376987 · 2003-12-01

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2NCT00135772 · 2003-10-01

Contingent Incentives Plus Bupropion for Smoking in People With SchizophreniaNCT00136760 · 2003-09-01

Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaNCT00218218 · 2002-06-01

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyNCT00310115 · 2002-04-01

Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1NCT00124683 · 2001-09-01

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1NCT00046813 · 2001-08-01

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerNCT00002520 · 1990-12-07

Treating Schizophrenic Smokers: Effects on Craving, Cues and WithdrawalNCT00781755

Common interventions

Leading sponsors

National Institute on Drug Abuse (NIDA) 6 Wake Forest University Health Sciences 5 National Cancer Institute (NCI) 4 British Columbia Cancer Agency 3 Brown University 3 Roswell Park Cancer Institute 3 University of Minnesota 3 Duke University 2 Mayo Clinic 2 Medical University of South Carolina 2 VA Office of Research and Development 2 Yale University 2 Butler Hospital 1 Centre for Addiction and Mental Health 1 Dartmouth-Hitchcock Medical Center 1

Trial status mix

COMPLETED45

UNKNOWN4

TERMINATED3

ACTIVE_NOT_RECRUITING2

RECRUITING2

WITHDRAWN2

ENROLLING_BY_INVITATION1

Phase mix

PHASE222

NA21

PHASE15

PHASE45

EARLY_PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.